Please see full Important Safety Information below in the pinned post and
at https://www.xiidra-ecp.com/sitemap/#isi.
This product information is intended for US Healthcare audiences only.
Xiidra is a Bausch + Lomb brand and is not associated with any individual
users on LinkedIn.
You are encouraged to report negative side effects of prescription drugs to
the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information at XIIDRA-ECP.com.
Xiidra is a trademark of Bausch + Lomb Incorporated or its affiliates.
© 2024 Bausch + Lomb | XDR.0273.USA.24
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.xiidra-ecp.com/
- Keywords
- Representative jobs.
Xiidra® (Lifitegrast Ophthalmic Solution) 5% Questions
Xiidra® (Lifitegrast Ophthalmic Solution) 5%'s website is https://www.xiidra-ecp.com/
Xiidra® (Lifitegrast Ophthalmic Solution) 5%'s LinkedIn profile is https://www.linkedin.com/company/xiidra
Xiidra® (Lifitegrast Ophthalmic Solution) 5%'s industry is
Pharmaceutical Manufacturing
Xiidra® (Lifitegrast Ophthalmic Solution) 5%'s top competitors are
Bausch + Lomb,
Abbvie,
Miebo® (Perfluorohexyloctane Ophthalmic Solution),
Tarsus Pharmaceuticals, Inc.,
Zeiss Medical Technology,
Alcon,
Rxsight, Inc.,
Zenni Optical,
Optos,
Coopervision.
Xiidra® (Lifitegrast Ophthalmic Solution) 5%'s categories are Pharmaceutical Manufacturing
